Circle Unicorn News - October 11, 2024Circle Pharma and Boehringer Ingelheim have announced a new partnership to develop a precision cancer treatment targeting cyclin-dependent kinases. This collaboration could potentially lead to innovative treatments for hard-to-treat cancers.Sourceshttps://www.pharmaceutical-technology.com/news/boehringer-circle-cancer-treatment/Outline(00:00:00) Introduction(00:00:32) Circle Pharma Partners with Boehringer to Develop New Cancer TreatmentAbout LinqtoAt Linqto, we empower investors with real-time insights and access to private AI companies, ensuring you stay ahead in the fast-evolving tech landscape. Our platform provides unparalleled opportunities to invest in high-potential startups and unicorns before they go public.View Linqto Products: https://www.linqto.com/products/Find all the Unicorn News on Linqto: https://www.linqto.com/unicorn-news/View Circle on Linqto: https://www.linqto.com/products/circle